NCT06995833View on ClinicalTrials.gov

Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance

RecruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

September 19, 2025

Primary Completion Date

June 29, 2029

Study Completion Date

June 29, 2029

Conditions

Endometrial Cancer

Trial Locations (1)

Unknown

RECRUITING

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY